Irvine-based Helio Genomics announces partnership with Quest Diagnostics to distribute its liver cancer detection test ...
PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine ...
Partnership expands access to breakthrough blood-based cancer screening into Superpower's comprehensive health check and personalized plans. SAN FRANCISCO, April 1, 2026 /PRNewswire/ -- Superpower, ...
New cfDNA test enables multicancer detection with high accuracy, offering a cost effective approach for early diagnosis and screening.
A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), the most common ...
Integration Will Enable Approximately 450 Health Systems to Access the Galleri Test Results Within Their Existing Patient Portal. Collaboration With Epic Will Allow Clinicians to ...
7d
PinkDx Publishes Groundbreaking Evidence in Endometrial Cancer Detection Using a Simple Vaginal Swab
The Gyne Cancer Company™ — today announced the publication of peer-reviewed evidence demonstrating that molecular signals ...
IRVINE, Calif., April 7, 2026 /PRNewswire/ -- Helio Genomics, Inc., an AI-powered TechBio company focused on early cancer detection, today announced the appointment of John Doyle to its Board of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results